Viewing Study NCT04952766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2026-01-05 @ 5:11 PM
Study NCT ID: NCT04952766
Status: COMPLETED
Last Update Posted: 2025-12-23
First Post: 2021-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults
Sponsor: Centre Hospitalier Régional d'Orléans
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Transplant View
None Myeloma View
None Cancer View
None Hematologic Malignancy View
None Multiple Sclerosis View
None Hypergammaglobulinemia View
None Malignant Tumor View
None Hiv View
None Diabetes Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SARS-CoV-2 View
None BNT162b2 vaccine View
None antibody View
None neutralization View
None mucosa View
None immunocompromised View
None healthy subject View